Sano’s Projects

At Sano Centre for Computational Medicine, we are proud to showcase the diverse and wide-ranging set of projects that our teams and individual researchers are undertaking, thanks to the support from a variety of funding sources including European and Polish grants. Each project reflects our commitment to advancing the field of Computational Medicine through innovative research, interdisciplinary collaboration, and the application of advanced computing technologies to solve complex medical challenges.

Here, you will find detailed insights into the aims, and impacts of our ongoing and completed projects.

These initiatives not only contribute to scientific knowledge but also aim to enhance healthcare outcomes, demonstrating our dedication to improving patient care through scientific excellence.

EU

Teaming for Excellence (2019 – 2026)

InSilicoWorld ISW  (2021 – 2024)

NearData (2023 – 2025) 

GEMINI (2023 – 2029)

InSilicoHealth

(2025 – 2029)


NCN

Weave 2023/05/Y/NZ2/00080

Sonata 2023/51/D/NZ7/02596 

Preludium 2023/49/N/ST6/04252

Preludium 2023/49/N/ST6/01841

Preludium  2024/53/N/NZ4/03513

ThromboRisk

(2025-2029)


Teaming for Excellence  

The goal of the Teaming for Excellence initiative is to establish a world-class research and innovation hub in Kraków, Poland. The Centre will focus its activities on computational diagnostics, a field at the forefront of technological transformation in healthcare. By leveraging advanced statistical models, machine learning, and large-scale data analysis, it will play a pivotal role in the prevention, diagnosis, and treatment of complex diseases.

The Centre aims to streamline healthcare systems, reduce treatment costs, and improve patient outcomes across Europe. As a catalyst for change, it seeks to reshape the future of medicine through computational innovation.

Strategic Objectives: 

  • Conduct advanced research and development in personalised diagnostics and treatment.
  • Support the healthcare industry through modern, high-impact technological solutions.
  • Accelerate the transfer of knowledge and technology within the healthcare sector.
  • Attract investment, foster start-ups, and promote international collaboration.

Teaming project website: https://cordis.europa.eu/project/id/857533 

Duration: 1 August 2019 – 31 July 2026 

Project lead: Maciej Malawski (Research Team Leader of Extreme-scale Data and Computing) 

H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions 

Partners/ List of collaborators:

Partners/ List of collaborators:  

  • Centre for New Methods in Computational Diagnostics and Personalised Therapy – Centre (PL) – Coordinator  
  • Narodowe Centrum Badań i Rozwoju  NCBR  (PL)  
  • Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie (PL) 
  • Akademickie Centrum Komputerowe Cyfronet – Cyfronet  (PL)  
  • Fundacja Klaster LifeScience Kraków – KLSK (PL) 
  • FraunhoferGesellschaft zur Förderung der angewandten Forschung e.V – Fraunhofer (DE)   
  • The University of Sheffield  – USFD (UK) 
  • Forschungszentrum Jülich GmbH  – FZJ  (DE)

NEARDATA 

The goal of  NEARDATA  is to create an extreme data infrastructure mediating data flows between Object Storage and Data Analytics platforms across the Compute Continuum. Novel XtremeDataHub platform is an intermediary data service that intercepts and optimises data flows (S3 API, stream APIs) with high performance near-data connectors (Cloud/Edge).   

Sano Team is responsible for:

  • Developing a pipeline for building transcriptomics atlas of selected tissues/diseases, with the use of HPC and Cloud technologies;
  • Federated Learning framework – a set of tools for running Federated Learning experiments on large scale genomics data.

NEARDATA  project website:  https://neardata.eu/ 

Duration: 01 January 2023 – 31 December 2025 

Project lead: Maciej Malawski (Extreme-scale Data and Computing)

Partners/ List of collaborators:

  • Universitat Rovira i Virgili (ES) – Coordinator
  • Barcelona Supercomputing Center (ES)
  • Technische Universität Dresden (DE)
  • Deutsches Krebsforschungszentrum Heidelberg (DE)
  • European Molecular Biology Laboratory (DE)
  • EMC Information Systems International Unlimited Company (IE)
  • KIO Networks España SA (ES)
  • Sano – Centre for Computational Medicine (PL)
  • Scontain GMBH (DE)
  • UK Health Security Agency (UK)

ISW (In Silico World) 

The In Silico World project aims at accelerating the uptake of modelling and simulation technologies used for the development and regulatory assessment of medicines and medical devices, by lowering seven identified barriers: development, validation, accreditation, optimisation, exploitation, information, and training. 

This initiative employs computer models that leverage experimental data for hypothesis testing and outcome prediction. 

Work package:

Scalability and efficient computing (WP5 led by Sano)

This package focuses on creating a sophisticated, user-friendly simulation platform that ensures the repeatability, replicability, and reproducibility of simulation outcomes. It also aims to facilitate efficient access and utilization of computational and storage capacities, both locally and within major European e-infrastructures like PRACE, EOSC, Eudat, and upcoming EuroHPC initiatives. 

ISW (In Silico World)  project website:  https://insilico.world/ 

Duration: 1 January 2021 –31 December 2024 

Project lead: Marian Bubak (Scientific Affairs Director)

Partners/ List of collaborators:

  • Alma Mater StudiorumUniversità di Bologna (IT) – Coordinator
  • Universiteit van Amsterdam (NL)
  • Technische Universiteit Eindhoven (NL)
  • Università degli Studi di Catania (IT)
  • Virtual Physiological Human Institute for Integrative
  • Biomedical Research VZW
  • Katholieke Universiteit Leuven (BE)
  • Insilicotrials Technologies SRL
  • Universite de Liege (BE)
  • Erasmus Universitair Medisch Centrum Rotterdam (NL),
  • Budapesti Muszaki es Gazdasagtudomanyi Egyetem (HU)
  • Din Deutsches Institut Fuer Normung E.V. (DE)
  • Mimesis SRL
  • Rsscan International NV (BE)
  • Sano – Centre for Computational Medicine (PL)
Projekt GEMINI Sano

GEMINI

GEMINI is a project which promises to save lives and enhance the well-being of stroke patients, as it aims at improving diagnosis and treatment for acute ischaemic and haemorrhagic stroke.
This aim will be achieved by developing patient-specific decision-making tools and well-established models that can accurately assist in the diagnosis and stratification of stroke patients for tailored treatments.
Multi-organ and multi-scale Digital Twins models will be developed to improve our understanding of and support personalised treatment selection for this severe condition.

Work package:

Sano is responsible for quality assurance (QA) and ensuring proper verification and validation of software that encapsulates computational models of various types of strokes. For Sano, it is a third EC-funded project, along with the ongoing In Silico World and NearData projects. 

GEMINI project website: dth-gemini.eu

Duration: 01.12.2023 – 30.11.2029 

Project lead: Marian Bubak (Scientific Affairs Director)

Partners/ List of collaborators:

  • Academisch Medisch Centrum Bij de Universiteit van Amsterdam (AMC) – Coordinator (NL)

  • AMC Medical Research BV (NL)

  • University of Amsterdam (NL)

  • Erasmus Universitair Medisch Center Rotterdam (NL)

  • Politecnico di Milano (IT)

  • Neuravi Limited (IE)

  • National University of Ireland Galway (IE)

  • Universidad Pompeu Fabra (ES)

  • Budapesti Műszaki és Gazdaságtudományi Egyetem (HU)

  • Ansys France SAS (FR)

  • Sano Centrum Zindywidualizowanej Medycyny Obliczeniowej – Międzynarodowa Fundacja Badawcza (PL)

  • Rheinische Friedrich-Wilhelms-Universität Bonn (DE)

  • Insteps BV (NL)

  • Nico-Lab BV (NL)

  • Sim&Cure (FR)

  • Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie (PL)

  • Les Hôpitaux Universitaires de Genève (CH)

  • Zürcher Hochschule für Angewandte Wissenschaften (CH)

  • National Taiwan University (TW)

Weave 2023/05/Y/NZ2/00080  

Title: Evolutionary-scale interpretation of protein functions in the human gut microbiome. 

The Weave project aims to create a detailed atlas of human gut protein structures with functional annotations, centered around a Protein Universe Map for navigating the gut microbiome. Leveraging deep learning and evolutionary modeling, it focuses on the 40% of gut proteins with unknown functions. By using advanced tools like AlphaFold2 and deepFRI, overcomes the limitations of traditional annotation methods and paves the way for deeper insights into gut microbiota metabolism and future therapeutic discovery. 

Project Goals: 

  • Catalogue Construction: Assemble a detailed library of gut protein structures and their predicted functions, including modeling novel 3D structures. 
  • Diversity Exploration: Analyze the sequence and structural diversity of functionally unknown proteins within the global protein space. 
  • Evolutionary Tracing: Investigate evolutionary origins and potential relationships of gut proteins across different ecosystems. 
  • Function Prediction: Combine structural data with genomic context to infer biological functions of dark proteins. 

Duration: 19 January 2024 – 18 January 2028 

Project lead: Tomasz Kościółek (Research Team Leader of Structural and Functional Genomics Group) 

Partners/ List of collaborators: 

  • University of Basel

Sonata 2023/51/D/NZ7/02596  

Title: “One step to game changer”: combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes foot infections 

Antimicrobial resistance (AMR) poses a growing threat to public health, particularly in diabetic patients prone to severe infections such as diabetic foot infections (DFIs). DFIs can escalate rapidly, often leading to amputation or death, and are increasingly resistant to standard therapies. This interdisciplinary project aims to design and develop biocompatible antimicrobial nanoparticles (BANs) as an innovative solution for treating DFIs and combating AMR. Using AI-guided drug development, green-chemistry-based nanomaterials, and cutting-edge biological models—including patient-derived clinical isolates and human skin organoids—the project seeks to deliver effective and safe therapies. 

The work is a collaboration between the Łukasiewicz Research Network – Krakow Institute of Technology and Sano – Centre for Computational Personalised Medicine. 

Project Objectives: 

  1. Develop AI-powered drug selection tools
  • ComBiotic: Identifies synergistic antimicrobial combinations. 
  • CombiGuard: Predicts and evaluates potential side effects of drug interactions. 
  1. Create biocompatible nanocarriers
  • Design biopolysaccharide-based inclusion matrices (BIMs) to encapsulate AI-selected antimicrobials. 
  • Engineer self-organizing “Trojan horse” nanoparticles (BANs) that exploit bacteria’s increased sugar uptake in diabetic environments. 
  1. Evaluate biological effectiveness of BANs
  • Test antimicrobial efficacy in vitro against DFI-relevant pathogens (e.g., S. aureus, E. coli, P. aeruginosa). 
  • Assess cytotoxicity and selectivity using human keratinocyte models. 
  • Validate findings in vivo using mouse infection models and advanced human skin organoids to support personalized treatment development. 

Duration: 10 July 2024 9 Jul 2027 

Project lead: Barbara Pucelik (Łukasiewicz Research Network – Krakow Institute of Technology)

Sano’s project mentor: Tomasz Kościółek (Research Team Leader of Structural and Functional Genomics Group) 

Partners/ List of collaborators: 

  • Łukasiewicz KIT 

Preludium 2023/49/N/ST6/04252

Title: Understanding the influence of variation in venous anatomy on local haemodynamics in patients with deep vein thrombosis of the lower limb: statistical shape modelling approach. 

This project aims to improve the understanding and prediction of post-thrombotic syndrome (PTS) following deep vein thrombosis (DVT) in the lower limbs by investigating how local venous anatomy influences blood flow patterns associated with thrombus formation. Using a combination of Computational Fluid Dynamics (CFD) and Statistical Shape Models (SSM), the research will analyze both idealized and patient-specific venous geometries derived from medical imaging (CT/MRI) to identify key anatomical features linked to abnormal haemodynamics, such as low wall shear stress and retrograde flow. 

The core objective is to determine whether SSMs can efficiently characterize shape-related risk factors and reduce the need for computationally expensive CFD simulations in clinical workflows. By applying sensitivity analysis and uncertainty quantification methods, the project will establish a framework to assess how anatomical variability influences haemodynamic metrics, ultimately supporting more accurate and cost-effective patient-specific diagnosis and intervention planning. This novel application of SSM-CFD integration to venous disease has strong potential to enhance clinical decision-making in vascular medicine. 

Project Goals:  

The influence of the diversity of vein anatomy on the local anatomy hemodynamics in patients with venous thrombosis  deep lower limb: statistical technician shape modeling. 

Duration:  29 January 2024 – 28 August 2025 

Project lead: Magdalena Otta (PhD Student in Extreme-scale Data and Computing)

Partners/ List of collaborators: 

  • University of Sheffield 
  • Royal Free Hospital 

Preludium 2023/49/N/ST6/01841 

Title: Multimodal Deep Learning for Noninvasive Pulmonary Hypertension Diagnosis from Magnetic Resonance Imaging 

Pulmonary hypertension (PH) is characterized by elevated pressure in the pulmonary artery and affects approximately 1% of adults. The standard diagnostic method—cardiac catheterization—is invasive, expensive, and carries clinical risk. The project focuses on developing non-invasive deep learning techniques for estimating mean pulmonary artery pressure (mPAP) using cardiac MRI data.A dataset comprising multimodal MRI recordings and corresponding clinical information, collected by the University of Sheffield and Sheffield Teaching Hospitals, will be used to train and evaluate predictive models. Initial efforts will involve convolutional and transformer-based architectures applied to single-modality data. In subsequent stages, multimodal learning strategies will be implemented by integrating diverse imaging data and structured patient information. To ensure clinical interpretability, existing explainability tools will be applied and extended.  

Project Objectives: 

  • Development of benchmark deep learning models for mPAP prediction based on MRI. 
  • Design of multimodal architectures combining various imaging modalities. 
  • Integration of tabular clinical data to enhance prediction accuracy. 
  • Implementation of explainability methods to support clinical interpretability. 
  • Establishment of foundations for fully non-invasive cardiac diagnostics. 

Project Goals: 

The project aims to enhance current approaches to PH diagnosis through the utilization of deep learning techniques. 

The work is a collaboration between the Warsaw University of Technology  and Sano – Centre for Computational Personalised Medicine. 

Duration:  17 January 2024 16 January 2027 

Project lead: Michał Grzeszczyk (PhD Student in Medical Imaging and Robotics)

Partners/ List of collaborators: 

  • Warsaw University of Technology  
  • University of Sheffield 
  • Sheffield Teaching Hospitals NHS Foundation Trust 
  • Massachusetts General Hospital, Harvard Medical School 

Preludium  2024/53/N/NZ4/03513 

Title: Diffusion magnetic resonance imaging for accurate white matter tracking in peritumoral tissue to enhance surgical planning, precision, and prediction in neuro-oncology 

This project leverages diffusion MRI (dMRI) and tractography to map glioma-induced structural and connectivity changes in the brain. By combining imaging data with molecular markers, and applying advanced techniques such as spherical deconvolution, the project aims to improve fiber tracking in tumor-adjacent regions and provide deeper insights into tumor behavior. The ultimate goal is to develop reliable imaging biomarkers to support diagnosis, surgical planning, and understanding of glioma biology. 

Project Goals: 

  • Optimize preprocessing pipelines for large-scale dMRI datasets of glioma patients. 
  • Apply advanced tractography techniques, including spherical deconvolution, to improve reconstruction of white matter in peritumoral regions. 
  • Integrate imaging and molecular data to explore the relationship between tumor biology and structural brain connectivity. 
  • Support the development of imaging biomarkers to enhance glioma diagnosis, treatment planning, and research, especially when individual dMRI scans are not available. 

Duration:  16 January 2025 15 January 2027

Project lead: Joan Falco Roget (PhD Student in Computational Neuroscience)

Partners/ List of collaborators: 

  • The University of Messina